Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability

Nov.07.2024
Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability
E-cigarette brand Olit recently launched the Olit Hookalit X 20000, a disposable, hookah-style e-cigarette with 22ml of 0.35% nicotine liquid. Compared to the previous model, the Olit Hookalit 40000, the new product focuses primarily on portability.

Recently, 2Firsts noted that after the Olit Hookalit 40000, e-cigarette brand Olit has launched another disposable hookah-style e-cigarette, the Olit Hookalit X 20000. According to the distributor website Vapesourcing, the product emphasizes portability and features 22ml of 0.35% nicotine liquid.

 

Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability
Olit Hookalit X 20000|Image source: Olit official website

 

The following table compares the product specifications of the Olit Hookalit X 20000 with the previously released, high-puff e-cigarette product, Olit Hookalit 40000, from the same brand:

 

Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability
Product Parameter Comparison | Illustration: 2Firsts

 

An article on the Ecigator website reviewing the Olit Hookalit 40000 states:

 

"With a nicotine concentration of 0.35%, the Olit Hookalit 40000 is noticeably lower than the 5% concentration commonly found in many other disposable e-cigarettes."

 

"From this perspective, the effect of vaping 40,000 puffs with the Olit Hookalit is roughly equivalent to vaping 2,857 puffs from devices like the SMOK Morf Bar, which have a nicotine concentration of 5%. This means that while the number of puffs may seem impressive, the actual nicotine delivery per puff is much lower."

 

"The large battery and sizable e-liquid tank make this device somewhat bulky compared to other products on the market, resulting in poorer portability."

 

Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability
Olit Hookalit 40000 Review Article | Image source: ecigator

 

The comparison reveals that the new Olit Hookalit X 20000 has a reduced e-liquid capacity and fewer puffs, while its battery capacity has also been lowered accordingly.

 

Additionally, 2Firsts noticed that the Hookalit series of e-cigarettes from the Olit brand, which includes the Olit Hookalit X 20000, Olit Hookalit 40000, and another model, Olit Hookalit Mini, displayed on their official website, all feature a cylindrical shape and do not include the large screen designs that are currently popular on the market.

 

Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability
Olit brand disposable e-cigarette products | Image source: Olit official website

 

 The new Olit Hookalit X 20000, as the "portable" product in the Hookalit series, has already been listed on the official Olit brand website and is available on distributor websites such as Vapesourcing. The product is currently marked as "COMING SOON," with a price of approximately $15.99.

 

It is worth noting that the e-cigarette brand Olit is a subsidiary of Kangor Technology, which has also recently launched a new product, the Kanger SUBOX 50000. This product features an impressive 50,000 puffs and a low nicotine concentration of 0.35%.

 

Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability
Olit Trademark Registration Information | Image source: Tianyancha

 

2Firsts will continue to monitor the latest e-cigarette products and market trends globally, providing the public with accurate and authoritative industry information.

 

2Firsts' product column remains committed to delivering readers the latest product updates in the new tobacco field. We invite readers to submit insights and news on e-cigarette developments.

 

For unique perspectives or information, feel free to contact us at carrie.cai@2firsts.com or scan the QR code below.

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

2Firsts Interviews Harm Reduction Policy Expert Jeannie Cameron: WHO’s Rejection of Harm Reduction Is Undermining Global Tobacco Control
2Firsts Interviews Harm Reduction Policy Expert Jeannie Cameron: WHO’s Rejection of Harm Reduction Is Undermining Global Tobacco Control
As part of its GFN media partnership, 2Firsts spoke with FCTC expert Jeannie Cameron, who warns that the WHO’s rejection of harm reduction is leading global tobacco control efforts off course.
Jun.18
Celebrating a Decade: Vapouround Global Awards Held in Dubai, 2Firsts Invited for On-Site Coverage
Celebrating a Decade: Vapouround Global Awards Held in Dubai, 2Firsts Invited for On-Site Coverage
The Vapouround 10th Anniversary Global Awards Ceremony was grandly held in Dubai, bringing together brand representatives, industry experts, and opinion leaders from around the world. Multiple major awards were announced on-site to celebrate a decade of industry achievements. 2Firsts was invited to attend and provide on-site coverage.
Jun.19 by 2FIRSTS.ai
2Firsts Successfully Hosts Global NGP Market Trends Forum at Shenzhen
2Firsts Successfully Hosts Global NGP Market Trends Forum at Shenzhen
On June 6, 2Firsts successfully hosted the Global NGP Market Trends Forum at Shenzhen, bringing together experts from regulatory, technology, and design sectors to explore compliance trends, product innovation, and market opportunities in the e-cigarette industry.
Jun.10 by 2FIRSTS.ai
15 EU Countries Call on Commission to Set Minimum Tax Rates for E-Cigarettes, Nicotine Pouches, and Heated Tobacco
15 EU Countries Call on Commission to Set Minimum Tax Rates for E-Cigarettes, Nicotine Pouches, and Heated Tobacco
Fifteen EU countries have urged the European Commission to revise tobacco tax rules for the first time since 2011. They call for minimum tax rates on e-cigarettes, nicotine pouches, and heated tobacco, and higher taxes on cigarettes and cigars to tackle health risks and illegal trade.
May.27 by 2FIRSTS.ai
Selangor, Malaysia Mulls Full E-Cigarette Sales Ban; Policy Proposal to be Reviewed
Selangor, Malaysia Mulls Full E-Cigarette Sales Ban; Policy Proposal to be Reviewed
The Selangor state government is evaluating a potential full ban on e-cigarette sales, with a policy proposal set to be presented to the state executive council for review, considering health and social impacts. Earlier, Terengganu announced a complete e-cigarette sales ban starting in August.
May.13 by 2FIRSTS.ai
FDA Launches National Priority Review Program: Drugs Aligned with U.S. Priorities May Be Approved in as Little as One Month
FDA Launches National Priority Review Program: Drugs Aligned with U.S. Priorities May Be Approved in as Little as One Month
The FDA has launched the Commissioner’s National Priority Voucher (CNPV) program, reducing the review time for certain drugs to as little as 1–2 months. While the program currently applies only to pharmaceuticals, it demonstrates the FDA’s capacity to reform its review pathways. Whether a similar mechanism could extend to tobacco products now appears to be a matter of timing and technical details.
Jun.18